The bovine basic pancreatic trypsin inhibitor (Kunitz inhibitor): a milestone protein. 2003

Paolo Ascenzi, and Alessio Bocedi, and Martino Bolognesi, and Andrea Spallarossa, and Massimo Coletta, and Raimondo De Cristofaro, and Enea Menegatti
Dipartimento di Biologia, Università Roma Tre, Italy. ascenzi@uniroma3.it

The pancreatic Kunitz inhibitor, also known as aprotinin, bovine basic pancreatic trypsin inhibitor (BPTI), and trypsin-kallikrein inhibitor, is one of the most extensively studied globular proteins. It has proved to be a particularly attractive and powerful tool for studying protein conformation as well as molecular bases of protein/protein interaction(s) and (macro)molecular recognition. BPTI has a relatively broad specificity, inhibiting trypsin- as well as chymotrypsin- and elastase-like serine (pro)enzymes endowed with very different primary specificity. BPTI reacts rapidly with serine proteases to form stable complexes, but the enzyme: inhibitor complex formation may involve several intermediates corresponding to discrete reaction steps. Moreover, BPTI inhibits the nitric oxide synthase type-I and -II action and impairs K+ transport by Ca2+-activated K+ channels. Clinically, the use of BPTI in selected surgical interventions, such as cardiopulmonary surgery and orthotopic liver transplantation, is advised, as it significantly reduces hemorrhagic complications and thus blood-transfusion requirements. Here, the structural, inhibition, and bio-medical aspects of BPTI are reported.

UI MeSH Term Description Entries
D007611 Aprotinin A single-chain polypeptide derived from bovine tissues consisting of 58 amino-acid residues. It is an inhibitor of proteolytic enzymes including CHYMOTRYPSIN; KALLIKREIN; PLASMIN; and TRYPSIN. It is used in the treatment of HEMORRHAGE associated with raised plasma concentrations of plasmin. It is also used to reduce blood loss and transfusion requirements in patients at high risk of major blood loss during and following open heart surgery with EXTRACORPOREAL CIRCULATION. (Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995) BPTI, Basic Pancreatic Trypsin Inhibitor,Basic Pancreatic Trypsin Inhibitor,Bovine Kunitz Pancreatic Trypsin Inhibitor,Kallikrein-Trypsin Inactivator,Kunitz Pancreatic Trypsin Inhibitor,Trypsin Inhibitor, Basic, Pancreatic,Trypsin Inhibitor, Kunitz, Pancreatic,Antilysin,Bovine Pancreatic Trypsin Inhibitor,Contrical,Contrykal,Dilmintal,Iniprol,Kontrikal,Kontrykal,Pulmin,Traskolan,Trasylol,Zymofren,Inactivator, Kallikrein-Trypsin,Kallikrein Trypsin Inactivator
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D010195 Pancreatitis INFLAMMATION of the PANCREAS. Pancreatitis is classified as acute unless there are computed tomographic or endoscopic retrograde cholangiopancreatographic findings of CHRONIC PANCREATITIS (International Symposium on Acute Pancreatitis, Atlanta, 1992). The two most common forms of acute pancreatitis are ALCOHOLIC PANCREATITIS and gallstone pancreatitis. Acute Edematous Pancreatitis,Acute Pancreatitis,Pancreatic Parenchyma with Edema,Pancreatic Parenchymal Edema,Pancreatitis, Acute,Pancreatitis, Acute Edematous,Peripancreatic Fat Necrosis,Acute Edematous Pancreatitides,Acute Pancreatitides,Edema, Pancreatic Parenchymal,Edematous Pancreatitides, Acute,Edematous Pancreatitis, Acute,Fat Necrosis, Peripancreatic,Necrosis, Peripancreatic Fat,Pancreatic Parenchymal Edemas,Pancreatitides, Acute,Pancreatitides, Acute Edematous,Parenchymal Edema, Pancreatic,Peripancreatic Fat Necroses
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D002417 Cattle Domesticated bovine animals of the genus Bos, usually kept on a farm or ranch and used for the production of meat or dairy products or for heavy labor. Beef Cow,Bos grunniens,Bos indicus,Bos indicus Cattle,Bos taurus,Cow,Cow, Domestic,Dairy Cow,Holstein Cow,Indicine Cattle,Taurine Cattle,Taurus Cattle,Yak,Zebu,Beef Cows,Bos indicus Cattles,Cattle, Bos indicus,Cattle, Indicine,Cattle, Taurine,Cattle, Taurus,Cattles, Bos indicus,Cattles, Indicine,Cattles, Taurine,Cattles, Taurus,Cow, Beef,Cow, Dairy,Cow, Holstein,Cows,Dairy Cows,Domestic Cow,Domestic Cows,Indicine Cattles,Taurine Cattles,Taurus Cattles,Yaks,Zebus
D002918 Chymotrypsin A serine endopeptidase secreted by the pancreas as its zymogen, CHYMOTRYPSINOGEN and carried in the pancreatic juice to the duodenum where it is activated by TRYPSIN. It selectively cleaves aromatic amino acids on the carboxyl side. Alpha-Chymotrypsin Choay,Alphacutanée,Avazyme
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Paolo Ascenzi, and Alessio Bocedi, and Martino Bolognesi, and Andrea Spallarossa, and Massimo Coletta, and Raimondo De Cristofaro, and Enea Menegatti
September 1986, Journal of molecular biology,
Paolo Ascenzi, and Alessio Bocedi, and Martino Bolognesi, and Andrea Spallarossa, and Massimo Coletta, and Raimondo De Cristofaro, and Enea Menegatti
May 1990, Biological chemistry Hoppe-Seyler,
Paolo Ascenzi, and Alessio Bocedi, and Martino Bolognesi, and Andrea Spallarossa, and Massimo Coletta, and Raimondo De Cristofaro, and Enea Menegatti
April 1983, The Journal of biological chemistry,
Paolo Ascenzi, and Alessio Bocedi, and Martino Bolognesi, and Andrea Spallarossa, and Massimo Coletta, and Raimondo De Cristofaro, and Enea Menegatti
January 1983, Biopolymers,
Paolo Ascenzi, and Alessio Bocedi, and Martino Bolognesi, and Andrea Spallarossa, and Massimo Coletta, and Raimondo De Cristofaro, and Enea Menegatti
January 1993, Journal of enzyme inhibition,
Paolo Ascenzi, and Alessio Bocedi, and Martino Bolognesi, and Andrea Spallarossa, and Massimo Coletta, and Raimondo De Cristofaro, and Enea Menegatti
January 1983, European journal of biochemistry,
Paolo Ascenzi, and Alessio Bocedi, and Martino Bolognesi, and Andrea Spallarossa, and Massimo Coletta, and Raimondo De Cristofaro, and Enea Menegatti
July 1984, Journal of molecular biology,
Paolo Ascenzi, and Alessio Bocedi, and Martino Bolognesi, and Andrea Spallarossa, and Massimo Coletta, and Raimondo De Cristofaro, and Enea Menegatti
June 1974, Biochemistry,
Paolo Ascenzi, and Alessio Bocedi, and Martino Bolognesi, and Andrea Spallarossa, and Massimo Coletta, and Raimondo De Cristofaro, and Enea Menegatti
August 1990, Biochimica et biophysica acta,
Paolo Ascenzi, and Alessio Bocedi, and Martino Bolognesi, and Andrea Spallarossa, and Massimo Coletta, and Raimondo De Cristofaro, and Enea Menegatti
June 1987, Biochemistry,
Copied contents to your clipboard!